ES2038722T3 - Procedimiento para preparar antagonistas de leucotrieno. - Google Patents

Procedimiento para preparar antagonistas de leucotrieno.

Info

Publication number
ES2038722T3
ES2038722T3 ES198888111747T ES88111747T ES2038722T3 ES 2038722 T3 ES2038722 T3 ES 2038722T3 ES 198888111747 T ES198888111747 T ES 198888111747T ES 88111747 T ES88111747 T ES 88111747T ES 2038722 T3 ES2038722 T3 ES 2038722T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
leucotrene
antagonists
leucotrene antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888111747T
Other languages
English (en)
Inventor
Gunther Dr. Wess
Wilhelm Prof. Dr. Bartmann
Gerhard Dr. Beck
Hiristo Anagnostopulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2038722T3 publication Critical patent/ES2038722T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

COMBINACIONES DE LA FORMULA(I) DONDE R1, R2, R3, R4, R5, R6 Y X TIENEN EL SIGNIFICADO DADO, METODO DE FABRICACION DE ESTAS COMBINACIONES, SU UTILIZACION COMO MEDICAMENTO Y PREPARACIONES FARMACEUTICAS SOBRE LA BASIS DE ESTAS COMBINACIONES ESTA DESCRITA.
ES198888111747T 1987-07-25 1988-07-21 Procedimiento para preparar antagonistas de leucotrieno. Expired - Lifetime ES2038722T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873724669 DE3724669A1 (de) 1987-07-25 1987-07-25 Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten

Publications (1)

Publication Number Publication Date
ES2038722T3 true ES2038722T3 (es) 1993-08-01

Family

ID=6332350

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888111747T Expired - Lifetime ES2038722T3 (es) 1987-07-25 1988-07-21 Procedimiento para preparar antagonistas de leucotrieno.

Country Status (16)

Country Link
US (1) US4855323A (es)
EP (1) EP0301402B1 (es)
JP (1) JPS6447729A (es)
KR (1) KR890001973A (es)
AT (1) ATE66468T1 (es)
AU (1) AU608868B2 (es)
DE (2) DE3724669A1 (es)
DK (1) DK412288A (es)
ES (1) ES2038722T3 (es)
FI (1) FI883454A7 (es)
GR (1) GR3002945T3 (es)
IL (1) IL87198A (es)
NO (1) NO167798C (es)
NZ (1) NZ225517A (es)
PT (1) PT88073B (es)
ZA (1) ZA885337B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9121656D0 (en) * 1991-10-11 1991-11-27 Ici Plc Chemical process
DE10355786A1 (de) * 2003-11-26 2005-06-30 Covion Organic Semiconductors Gmbh Konjugierte Polymere, deren Darstellung und Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867434A (en) * 1971-11-04 1975-02-18 Rorer Inc William H Phenyl butyric acids and derivatives thereof
US3894080A (en) * 1970-05-05 1975-07-08 Rorer Inc William H Phenylacetic acids
AT336589B (de) * 1974-05-20 1977-05-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylderivaten
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
GB2190377A (en) * 1986-05-14 1987-11-18 Merck Frosst Canada Inc Phenyldithiaalkanedioic acids as leukotriene antagonists

Also Published As

Publication number Publication date
ZA885337B (en) 1989-03-29
JPS6447729A (en) 1989-02-22
ATE66468T1 (de) 1991-09-15
IL87198A0 (en) 1988-12-30
NZ225517A (en) 1990-11-27
AU608868B2 (en) 1991-04-18
DE3864345D1 (de) 1991-09-26
KR890001973A (ko) 1989-04-07
DK412288D0 (da) 1988-07-22
EP0301402A1 (de) 1989-02-01
EP0301402B1 (de) 1991-08-21
DE3724669A1 (de) 1989-02-02
PT88073A (pt) 1989-06-30
DK412288A (da) 1989-01-26
FI883454A0 (fi) 1988-07-21
FI883454A7 (fi) 1989-01-26
AU1929588A (en) 1989-01-27
US4855323A (en) 1989-08-08
NO883285D0 (no) 1988-07-22
NO883285L (no) 1989-01-26
PT88073B (pt) 1995-03-01
GR3002945T3 (en) 1993-01-25
NO167798C (no) 1991-12-11
NO167798B (no) 1991-09-02
IL87198A (en) 1992-11-15

Similar Documents

Publication Publication Date Title
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
NO2002009I2 (no) Tiotropium
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
DK203787A (da) Praeparat til nasal administrering
ES2058061T3 (es) Derivado de piperidina, su preparacion y su uso como medicamento.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE8505112D0 (sv) Novel pharmacological compounds
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
ES2017932B3 (es) Compuestos azaciclicos, procedimientos de su preparacion y su uso como farmacos.
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
ATE94764T1 (de) Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
ES2038722T3 (es) Procedimiento para preparar antagonistas de leucotrieno.
ES2040783T3 (es) Procedimiento para preparar antagonistas de leucotrienos.
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
NO873934L (no) Saarhelende serotoninantagonistisk forbindelse.
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301402

Country of ref document: ES